Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using Salt Substitute to Reduce Population Blood Pressure in Tibet: Tibet Salt Reduction Study

NCT02021435 is registered in ClinicalTrials.gov with Beijing Jishuitan Hospital as lead sponsor.

NCT NCT02021435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02021435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using Salt Substitute to Reduce Population Blood Pressure in Tibet: Tibet Salt Reduction Study
Lead sponsor
Beijing Jishuitan Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2014
Completion date
Not reported
Enrollment
4,500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, cardiovascular diseases, death